Dwayne Lashyn is listed as a director on 12 SEC Form D filings by 4 issuers between Jul 2016 and Mar 2023: Prairie Plant Systems Inc. (Saskatoon, Saskatchewan, Canada (as filed: A9) — biotechnology — 2016; $6.47M reported sold to 12 investors), CanniMed Therapeutics Inc. (Saskatoon, Saskatchewan, Canada (as filed: A9) — biotechnology — 2017; $5.15M reported sold to 5 investors), Ethicann Pharmaceuticals Inc. (Toronto, Ontario, Canada (as filed: A6) — pharmaceuticals — 2019–2022; $25K reported sold to 1 investors) and Ethicann Pharmaceuticals Inc. / DE (Bethesda, MD — pharmaceuticals — 2023).
What this means A repeat sponsor — 4 separate companies raised money with this person listed as director, over about 7 years. Across those companies the filings report $11.6M sold in total.
Listed alongside Brandon Price (12 shared filings), Bruce F Mackler (12 shared filings), Neil Maruoka (6 shared filings), James Wishart (5 shared filings), Richard Hoyt (5 shared filings) and 18 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Dwayne. Each name links to their own page.
The issuers belong to 2 sponsor groups: Prairie (2 issuers, $11.6M reported sold, 2016–2017) and Ethicann Pharmaceuticals (2 issuers, $25K reported sold, 2019–2023).
What this means This person is listed across more than one sponsor team; each group page shows that team's full track record.
Public records searched: federal courts (CourtListener / RECAP), state securities regulators (AZ, CA, DE, TX, WA) — none found. Not yet searched: SEC enforcement releases (search queued; results are added automatically).
What this means Nothing turned up where we looked (2 sources). That does not prove there is nothing — it means none was found in those sources on that date.